Infectious diseases

COPD Foundation Condemns Big Tobacco Acquisition of Pharmaceutical Company

Retrieved on: 
Thursday, July 29, 2021
Other Health, General Health, Pharmaceutical, Philanthropy, Oncology, Medical devices, Infectious diseases, Retail, Foundation, Science, Other Science, Health, Health effects of tobacco, Chronic lower respiratory diseases, Chronic obstructive pulmonary disease

The COPD Foundation condemns this acquisition.

Key Points: 
  • The COPD Foundation condemns this acquisition.
  • A company that profits from the sale of products that cause COPD should not benefit from the sale of products that treat COPD.
  • Patients, Providers, Payers, and Pharmacies will likely face the ethical dilemma as to whether it is appropriate to use treatments that profit Big Tobacco, stated Dr. Byron Thomashow, COPD Foundations Chief Medical Officer.
  • The position of Phillip Morris that those who oppose the alliance of Big Tobacco and Pharma are promoting the continuing sale of tobacco products is preposterous.

EY Announces Ling Chai Maginn of Jenzabar as an Entrepreneur Of The Year 2021 New England Award Winner

Retrieved on: 
Thursday, July 29, 2021
VoIP, Software, Professional services, Data management, Training, Technology, Other Education, Infectious diseases, Continuing, Education, Other Technology, Health, Consulting, Chai Ling, Converts to Christianity, Ernst & Young, Ling, Human rights in China, Chinese people

Ernst & Young LLP (EY US) today announced that Ling Chai Maginn Jenzabar President, CEO, and Founder was named an Entrepreneur Of The Year 2021 New England Award winner.

Key Points: 
  • Ernst & Young LLP (EY US) today announced that Ling Chai Maginn Jenzabar President, CEO, and Founder was named an Entrepreneur Of The Year 2021 New England Award winner.
  • Ling was selected by an independent panel of judges, and the award was announced during the programs virtual awards gala on July 28, 2021.
  • I'm truly honored to win this award and stand in the footsteps of so many people who I've admired, said Ling Chai Maginn, Founder, President, CEO, and Chairwoman of the Board of Jenzabar.
  • As a New England award winner, Ling is now eligible for consideration for the Entrepreneur Of The Year 2021 National Awards.

Good Neighbor Pharmacy Hosts Virtual ThoughtSpot 2021 Conference & Trade Show

Retrieved on: 
Thursday, July 29, 2021
Medical Supplies, Biotechnology, Practice Management, Education, Managed care, Health, General Health, Pharmaceutical, Training, Infectious diseases, Continuing, Health care, AmerisourceBergen, Health sciences, Good Neighbor Pharmacy, Health, Pharmacy, ThoughtSpot, Pharmacist, Family Pharmacy, ThoughtSpot, AmerisourceBergen, THOUGHTSPOT, AMERISOURCEBERGEN

Today, AmerisourceBergen and Good Neighbor Pharmacy kicked off the final day of ThoughtSpot, Good Neighbor Pharmacys annual conference and trade show representing its commitment to supporting independent pharmacies as community healthcare destinations and providing resources to optimize their business operations.

Key Points: 
  • Today, AmerisourceBergen and Good Neighbor Pharmacy kicked off the final day of ThoughtSpot, Good Neighbor Pharmacys annual conference and trade show representing its commitment to supporting independent pharmacies as community healthcare destinations and providing resources to optimize their business operations.
  • Additionally, Mahaska Drug of Oskaloosa, IA was announced as the winner of the annual Good Neighbor Pharmacy of the Year award, honoring excellence in patient care, community outreach, and innovative pharmacy practice.
  • During todays final general session event, AmerisourceBergen leaders announced Good Neighbor Pharmacys four key objectives to help independent community pharmacies thrive in the year ahead:
    Also announced during ThoughtSpot was Good Neighbor Pharmacys recent ranking on the J.D.
  • Our customers not only rose to the challenge but went above and beyond for their communities, said Brian Nightengale, RPh, PhD, President of Good Neighbor Pharmacy.

Delta Variant? There Are Others. Milford Molecular Diagnostics Laboratory Routinely Diagnoses Variants of SARS-CoV-2, Including Alpha, Beta, Gamma, Delta, Epsilon, Eta, Iota, Kappa and Lambda Variants

Retrieved on: 
Thursday, July 29, 2021
Health, Infectious diseases, Branches of biology, Biology, Biotechnology, Life sciences, Molecular biology, Laboratory techniques, Polymerase chain reaction, DNA, Molecular diagnostics, DNA sequencing, Reverse transcription polymerase chain reaction

Sin Hang Lee, director of Milford Molecular Diagnostics, summarizing recently published sequence-based surveillance data.

Key Points: 
  • Sin Hang Lee, director of Milford Molecular Diagnostics, summarizing recently published sequence-based surveillance data.
  • View the full release here: https://www.businesswire.com/news/home/20210729006029/en/
    However, he added, there exists no known diagnostic method for these variants in the U.S. for individual patient samples outside of Milford Diagnostics Laboratory.
  • All variants of concern or of interest must have at least one of these 8 mutated amino acids.
  • Milford Molecular Diagnostics Laboratory is CLIA-certified to perform nested RT-PCR/DNA sequencing for diagnosis of SARS-Co-V-2 and reflex spike protein gene sequencing for variant determination.

UK Biomanufacturing Team to Spearhead Development of Advanced Controls to Accelerate Drug and Vaccine Manufacturing

Retrieved on: 
Thursday, July 29, 2021
Biotechnology, General Health, Infectious diseases, Health, Pharmaceutical, Biotechnology, Bioprocess, Pharmaceutical industry, Natural sciences, Manufacturing, National Health Service, Medication, NHS Scotland, Articles, Nature, CPI, Pall Corporation, Biopharm Services, SCIEX, BiologIC Technologies, CPI, PALL CORPORATION, BIOPHARM SERVICES, SCIEX, BIOLOGIC TECHNOLOGIES

The project, worth a total of 3.1million, including equipment contributions, has received support from Innovate UK, to platform this advanced technology.

Key Points: 
  • The project, worth a total of 3.1million, including equipment contributions, has received support from Innovate UK, to platform this advanced technology.
  • This will ultimately reduce manufacturing costs and improve product quality, lowering costs to the NHS, and increasing access to life-changing drugs for patients.
  • The continuous bioprocessing module will be linked to the BioSolve Process cost modelling platform of lead partner Biopharm Services.
  • By clarifying the business case using BioSolve Process and actively sharing practical control strategies, the consortium will advance UK biopharmaceutical manufacturing.

New Harris Poll: Cybersecurity Fears May Stall COVID-19 Digital Vaccine Card Adoption in the United States and United Kingdom, Identity Theft and Fake Cards Top List of Concerns

Retrieved on: 
Thursday, July 29, 2021
Software, Pharmaceutical, Health, Data management, Infectious diseases, Technology, Mobile, Wireless, Security, Articles, Data security, Cyberwarfare, Anomali, COVID-19, Vaccination, Computer security, Computing, The Harris Poll, Anomali, THE HARRIS POLL, ANOMALI

Anomali , the leader in intelligence-driven cybersecurity solutions, today announced availability of its latest survey conducted by The Harris Poll.

Key Points: 
  • Anomali , the leader in intelligence-driven cybersecurity solutions, today announced availability of its latest survey conducted by The Harris Poll.
  • However, doubt remains, as 23% of U.S. respondents and 26% in the U.K. said they are somewhat likely.
  • Among key findings:
    80% of Americans and 76% of those in the U.K. have cybersecurity concerns related to COVID-19 digital vaccination cards.
  • 93% of Americans and 89% of British adults have smartphones capable of supporting COVID-19 digital vaccination cards.

New Harris Poll: Cybersecurity Fears May Stall COVID-19 Digital Vaccine Card Adoption in the United Kingdom, Identity Theft and Fake Cards Top List of Concerns

Retrieved on: 
Thursday, July 29, 2021
Software, Pharmaceutical, Health, Data management, Infectious diseases, Technology, Mobile, Wireless, Security, Biotechnology, Vaccination, Articles, Medicine, Life sciences, Immunology, Passports, Medical research, COVID-19 vaccine card, The Harris Poll, Anomali, THE HARRIS POLL, ANOMALI

Among key findings:

Key Points: 
  • Among key findings:
    76% have cybersecurity concerns related to COVID-19 digital vaccination cards.
  • Identity theft topped the list at 51%, with fake vaccine cards that could be used to hack smartphones (44%) and data breaches (45%) close behind.
  • A full 21% rejected the idea of using digital vaccine cards, stating they are not likely to use them at all.
  • 64% expect that COVID-19 digital vaccination cards will lead to a cyberattack causing moderate to major disruption to business, government, and consumers.